Who we are
The Chronic Care Center is a medico-social institution, specialized in the treatment and follow-up of childhood chronic diseases: Thalassemia and Type I Diabetes.
Our Clinical Report
The clinical Report is a result of continuous research on Diabetes and Thalassemia. It covers all facts and figures, and a overview of the Clinical Centers Yearly accomplishements, along with acccurate cost of treatments.
Download the Report
PUBLICATIONS
110 references
The Chronic Care Center is a comprehensive thalassemia care center. In its continuous effort to strive for excellence, the center always participates and pioneers in cutting edge research in this domain. The center's staff is a global leader in their fields and references in regard to their clinical practice. Together, and due to their esteemed scientific positions, have put Lebanon and the chronic care center in the global spotlight again.
Over the last 5 years, we have published a lot in the field of thalassemia, looking into iron overload, specific morbidities, iron chelation therapy, quality of life, and novel therapies.
Apply Filter
Search our archive
per Year | & month
Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand.
Am J Hematol. 2019 Oct;94(10):E261-E264. doi: 10.1002/ajh.25584. Epub 2019 Aug 13. No abstract available.
Cappellini MD, Kattamis A, Viprakasit V, Sutcharitchan P, Pariseau J, Laadem A, Jessent-Ciaravino V, Taher A, 13 Aug 2019.
Thalassemia and malignancy: An emerging concern?
Blood Rev. 2019 Sep;37:100585. doi: 10.1016/j.blre.2019.06.002. Epub 2019 Jun 22. Review.
Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, Noureldine HA, Noureldine MHA, Taher AT, 22 Jun 2019.
Development of a thalassemia-related thrombosis risk scoring system.
Am J Hematol. 2019 Aug;94(8):E207-E209. doi: 10.1002/ajh.25502. Epub 2019 May 13. No abstract available.
Taher AT, Cappellini MD, Musallam KM, 13 May 2019.
Cardiac involvement in beta-thalassaemia: current treatment strategies.
Postgrad Med. 2019 May;131(4):261-267. doi: 10.1080/00325481.2019.1608071. Epub 2019 May 6. Review.
Paul A, Thomson VS, Refat M, Al-Rawahi B, Taher A, Nadar SK, 06 May 2019.
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
Am J Hematol. 2019 Apr;94(4):E96-E99. doi: 10.1002/ajh.25408. Epub 2019 Jan 31. No abstract available.
Taher AT, Origa R, Perrotta S, Kouraklis A, Belhoul K, Huang V, Han J, Bruederle A, Bobbili P, Duh MS, Porter JB, 31 Jan 2019.
Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis.
Int J Mol Sci. 2018 Dec 17;19(12). pii: E4070. doi: 10.3390/ijms19124070. Review.
Finianos A, Matar CF, Taher A, 17 Dec 2018.
Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
Ann Hematol. 2019 Apr;98(4):833-840. doi: 10.1007/s00277-018-3567-3. Epub 2018 Nov 30.
Brancaleoni V, Moukhadder HM, Consonni D, Koussa S, Di Pierro E, Cappellini MD, Taher A, 30 Nov 2018.
Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.
Am J Hematol. 2019 Feb;94(2):E43-E45. doi: 10.1002/ajh.25339. Epub 2018 Nov 29. No abstract available.
Sharara AI, Rustom LBO, Marrache M, Rimmani HH, Bou Daher H, Koussa S, Taher A, 29 Nov 2018.
Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).
Am J Hematol. 2019 Feb;94(2):171-176. doi: 10.1002/ajh.25343. Epub 2018 Nov 26.
Taher A, Viprakasit V, Cappellini MD, Sutcharitchan P, Ward R, Mahmoud D, Laadem A, Khan A, Gwaltney C, Harding G, Attie K, Zhang X, Zou J, Pariseau J, Hu XH, Kattamis A, 26 Nov 2018.
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).
Am J Hematol. 2019 Feb;94(2):177-183. doi: 10.1002/ajh.25344. Epub 2018 Nov 26.
Taher A, Cappellini MD, Viprakasit V, Sutcharitchan P, Mahmoud D, Laadem A, Khan A, Gwaltney C, Harding G, Attie K, Zhang X, Zou J, Pariseau J, Henry Hu X, Kattamis A, 26 Nov 2018.